Pathology Grand Rounds -WHO 2016 CNS Tumor and cIMPACT-NOW updates
At the conclusion of this lecture, participants will:
* Gain appreciation for the newly defined 2016 WHO integrated (pathology and molecular) brain tumor diagnoses
* Learn about new immunohistochemical stains that can be utilized as surrogates for molecular alterations in CNS neoplasms
* Enhance their understanding of molecular diagnostics in patient management for CNS tumors